Most top-selling liver supplements on Amazon lack strong scientific evidence for safety or efficacy, with many relying on limited research.

HealthDay News — Nebraska is the first state to get federal approval to ban the purchase of soda and energy drinks under the Supplemental Nutrition Assistance Program (SNAP), also known as food stamps ...

Treatment with retifanlimab plus carboplatin-paclitaxel statistically significantly reduced the risk of progression or death by 37% compared with placebo plus carboplatin-paclitaxel.

China has promised to give $500 million to WHO over the next 5 years, positioning itself to become the group’s top donor.

US News & World Report has released its new over-the-counter (OTC) medicine and health product rankings for 2025.

The average annual national percentage change in mortality from hepatocellular carcinoma from 2005 to 2023 was higher for rural vs urban residents.

Metabolic dysfunction-associated steatotic liver disease in pregnant women is a risk factor for preterm birth.

Sarcopenia in the United States appears to be correlated to gallstone risk, most significantly among women, according to study results published in BMC Gastroenterology.

The FDA has designated Otulfi (ustekinumab-aauz) as an interchangeable biosimilar to the reference product Stelara ...

The FDA has announced that it is taking steps to remove concentrated ingestible fluoride prescription drug products for children from the market.

Obesity did not significantly impact colonic endoscopic submucosal dissection results, but overtubes were used more for right ...

GLP-1 RA treatment was linked to 8 fewer AHI events per hour among individuals with elevated body weight and moderate to severe OSA who did not have diabetes. Glucagon-like peptide-1 receptor agonists ...